Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18231104

Br. J. Cancer 2008 Feb 26 98 4 832-9

Download in:

View as

General Info

PMID
18231104